Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists' perspective

M. Lambertini, A. Toss, A. Passaro, C. Criscitiello, C. Cremolini, C. Cardone, F. Loupakis, G. Viscardi, I. Meattini, M.V. Dieci, R. Ferrara, R. Giusti, M.D. Maio

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalESMO Open
Volume5
Issue number2
DOIs
Publication statusPublished - 2020

Keywords

  • editorial
  • age
  • Article
  • cancer growth
  • cancer immunotherapy
  • cancer palliative therapy
  • cancer patient
  • cancer screening
  • cancer therapy
  • caregiver
  • coronavirus disease 2019
  • cytokine storm
  • differential diagnosis
  • European Medicines Agency
  • evidence based practice
  • follow up
  • Food and Drug Administration
  • health care personnel
  • hospital admission
  • human
  • infection risk
  • Italy
  • malignant neoplasm
  • medical oncologist
  • pandemic
  • risk factor
  • telemedicine
  • terminal care
  • therapy delay
  • treatment interruption
  • virus pneumonia
  • virus transmission
  • Betacoronavirus
  • China
  • Coronavirinae
  • Coronavirus infection
  • oncologist
  • SARS coronavirus
  • Coronavirus
  • Coronavirus Infections
  • Humans
  • Oncologists
  • Pandemics
  • Pneumonia, Viral
  • SARS Virus

Cite this